Republic of Korea In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture


December 28, 2012
263 Pages - SKU: GBDT4937508
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In Republic of Korea
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, Republic of Korea, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics Market, Republic of Korea, Revenue Mix ($m), 2011
3.4 In Vitro Diagnostics Market, Republic of Korea, Category Contribution (%), 2011
3.5 In Vitro Diagnostics, Republic of Korea, Company Share (2010-2011)
4 Clinical Chemistry In Republic of Korea
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, Republic of Korea, Revenue Mix ($m), 2011
4.3 Clinical Chemistry Market, Republic of Korea, Segment Contribution (%), 2011
4.4 Clinical Chemistry Overall Revenue, (2004-2018)
4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018)
4.4.2 Urine Analysis, Revenue (2004-2018)
4.5 Clinical Chemistry Distribution Share (2010-2011)
4.6 Clinical Chemistry, Republic of Korea, Company Share (2010-2011)
5 Genetic Testing In Republic of Korea
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, Republic of Korea, Revenue Mix ($m), 2011
5.3 Genetic Testing Market, Republic of Korea, Segment Contribution (%), 2011
5.4 Genetic Testing Overall Revenue, (2004-2018)
5.5 Genetic Testing Distribution Share (2010-2011)
5.6 Genetic Testing, Republic of Korea, Company Share (2010-2011)
6 Haematology In Republic of Korea
6.1 Haematology Market, Market Segmentation
6.2 Haematology Market, Republic of Korea, Revenue Mix ($m), 2011
6.3 Haematology Market, Republic of Korea, Segment Contribution (%), 2011
6.4 Haematology Overall Revenue, (2004-2018)
6.4.1 Haematology Reagents, Revenue (2004-2018)
6.4.2 Immunohaematology, Revenue (2004-2018)
6.4.3 Haemostasis, Revenue (2004-2018)
6.4.4 Haematology Rapid Tests, Revenue (2004-2018)
6.4.5 Haematology Cell Counters, Revenue (2004-2018)
6.5 Haematology Distribution Share (2010-2011)
6.6 Haematology, Republic of Korea, Company Share (2010-2011)
7 Histology And Cytology In Republic of Korea
7.1 Histology and Cytology Market, Market Segmentation
7.2 Histology And Cytology Market, Republic of Korea, Revenue Mix ($m), 2011
7.3 Histology And Cytology Market, Republic of Korea, Segment Contribution (%), 2011
7.4 Histology And Cytology Overall Revenue, (2004-2018)
7.5 Histology And Cytology Distribution Share (2010-2011)
7.6 Histology And Cytology, Republic of Korea, Company Share (2010-2011)
8 Immuno Chemistry In Republic of Korea
8.1 Immuno Chemistry Market, Republic of Korea, Revenue Mix ($m), 2011
8.2 Immuno Chemistry Market, Republic of Korea, Segment Contribution (%), 2011
8.3 Immuno Chemistry Overall Revenue, (2004-2018)
8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018)
8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018)
8.3.3 Endocrinology Tests, Revenue (2004-2018)
8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018)
8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018)
8.3.6 Immunochemistry Analyzers, Revenue (2004-2018)
8.4 Immuno Chemistry Distribution Share (2010-2011)
8.5 Immuno Chemistry, Republic of Korea, Company Share (2010-2011)
9 Infectious Immunology In Republic of Korea
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, Republic of Korea, Revenue Mix ($m), 2011
9.3 Infectious Immunology Market, Republic of Korea, Segment Contribution (%), 2011
9.4 Infectious Immunology Overall Revenue, (2004-2018)
9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018)
9.5 Infectious Immunology Distribution Share (2010-2011)
9.6 Infectious Immunology, Republic of Korea, Company Share (2010-2011)
10 Microbiology Culture In Republic of Korea
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, Republic of Korea, Revenue Mix ($m), 2011
10.3 Microbiology Culture Market, Republic of Korea, Segment Contribution (%), 2011
10.4 Microbiology Culture Overall Revenue, (2004-2018)
10.4.1 Microbiology Analyzers, Revenue (2004-2018)
10.5 Microbiology Culture Distribution Share (2010-2011)
10.6 Microbiology Culture, Republic of Korea, Company Share (2010-2011)
11 Overview of Key Companies in Republic of Korea In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Share in the Republic of Korea In Vitro Diagnostics Market
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Share in the Republic of Korea In Vitro Diagnostics Market
11.3 Siemens Healthcare
11.3.1 Company Overview
11.3.2 Share in the Republic of Korea In Vitro Diagnostics Market
11.4 Beckman Coulter, Inc.
11.4.1 Company Overview
11.4.2 Share in the Republic of Korea In Vitro Diagnostics Market
11.5 Sysmex Corporation
11.5.1 Company Overview
11.5.2 Share in the Republic of Korea In Vitro Diagnostics Market
11.6 Alere Inc.
11.6.1 Company Overview
11.6.2 Share in the Republic of Korea In Vitro Diagnostics Market
11.7 bioMerieux S.A.
11.7.1 Company Overview
11.8 Ortho-Clinical Diagnostics Inc.
11.8.1 Company Overview
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Company Overview
11.10 Hitachi Medical Corporation
11.10.1 Company Overview
11.11 Becton, Dickinson and Company
11.11.1 Company Overview
11.12 Toshiba Medical Systems Corporation
11.12.1 Company Overview
11.13 DiaSorin S.p.A
11.13.1 Company Overview
11.14 Qiagen N.V.
11.14.1 Company Overview
11.15 PerkinElmer, Inc.
11.15.1 Company Overview
11.16 Danaher Corporation
11.16.1 Company Overview
11.17 Mindray Medical International Limited
11.17.1 Company Overview
11.18 Thermo Fisher Scientific Inc.
11.18.1 Company Overview
11.19 Gen-Probe Incorporated
11.19.1 Company Overview
11.20 Nihon Kohden Corporation
11.20.1 Company Overview
11.21 Horiba, Ltd.
11.21.1 Company Overview
11.22 Life Technologies Corporation
11.22.1 Company Overview
11.23 Phadia AB
11.23.1 Company Overview
12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology And Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products
13 Financial Deals Landscape
13.1 Acquisition
13.1.1 Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company
13.2 Partnerships
13.2.1 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
13.2.2 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
13.2.3 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
13.2.4 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
13.2.5 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
13.2.6 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
13.2.7 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
13.2.8 CML HealthCare Enters Into Agreement With MaRS Innovation
13.2.9 Akrivis Technologies Enters Into Co-Development Agreement With United States Biological
13.2.10 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
13.2.11 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
13.2.12 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
13.2.13 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
13.2.14 Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers
13.2.15 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
13.2.16 Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems
13.2.17 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
13.2.18 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
13.2.19 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
13.2.20 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
13.2.21 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
13.2.22 One Lambda Enters Into Co-Marketing Agreement With CellTrend
13.2.23 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
13.2.24 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
13.2.25 Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing
13.2.26 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
13.2.27 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
13.2.28 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
13.2.29 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
13.2.30 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
13.2.31 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
13.2.32 LipoScience Enters Into Licensing Agreement With Cleveland Clinic
13.2.33 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
13.2.34 NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
13.2.35 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
14 Appendix
14.1 Definitions of Markets Covered in the Report
14.1.1 In Vitro Diagnostics
14.2 Research Methodology
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Forecasts
14.7 Expert Panels
14.8 GlobalData Consulting
14.9 Currency Conversion
14.10 Contact Us
14.11 Disclaimer
1.1 List of Tables
Table 1: In Vitro Diagnostics, Republic of Korea, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: In Vitro Diagnostics Market, Republic of Korea, Category Contribution (%), 2011
Table 3: In Vitro Diagnostics Market, Republic of Korea, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, Republic of Korea, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, Republic of Korea, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: Clinical Chemistry Market, Republic of Korea, Segment Contribution (%), 2011
Table 8: Clinical Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 9: Clinical Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 10: Clinical Chemisty Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 11: Clinical Chemisty Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 12: Urine Analysis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 13: Urine Analysis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 14: Clinical Chemistry, Republic of Korea, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Clinical Chemistry, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Genetic Testing Market, Republic of Korea, Segment Contribution (%), 2011
Table 17: Genetic Testing, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Genetic Testing, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Genetic Testing, Republic of Korea, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Genetic Testing, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Haematology Market, Republic of Korea, Segment Contribution (%), 2011
Table 22: Haematology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 23: Haematology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 24: Haematology Reagents, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 25: Haematology Reagents, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 26: Immunohaematology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 27: Immunohaematology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 28: Haemostasis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 29: Haemostasis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 30: Haematology Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 31: Haematology Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 32: Haematology Cell Counters, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 33: Haematology Cell Counters, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 34: Haematology, Republic of Korea, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: Haematology, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Histology And Cytology Market, Republic of Korea, Segment Contribution (%), 2011
Table 37: Histology And Cytology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 38: Histology And Cytology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 39: Histology And Cytology, Republic of Korea, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Histology And Cytology, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Immuno Chemistry Market, Republic of Korea, Segment Contribution (%), 2011
Table 42: Immuno Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 43: Immuno Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 44: Disease Specific Immunochemistry, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 45: Disease Specific Immunochemistry, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 46: Drugs of Abuse / Toxicology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 47: Drugs of Abuse / Toxicology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 48: Endocrinology Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 49: Endocrinology Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 50: Immunochemistry Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 51: Immunochemistry Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 52: Therapeutic Drug Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 53: Therapeutic Drug Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 54: Immunochemistry Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 55: Immunochemistry Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 56: Immuno Chemistry, Republic of Korea, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Immuno Chemistry, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Infectious Immunology Market, Republic of Korea, Segment Contribution (%), 2011
Table 59: Infectious Immunology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 60: Infectious Immunology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 61: Infectious Immunology Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 62: Infectious Immunology Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 63: Infectious Immunology, Republic of Korea, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 64: Infectious Immunology, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 65: Microbiology Culture Market, Republic of Korea, Segment Contribution (%), 2011
Table 66: Microbiology Culture, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 67: Microbiology Culture, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 68: Microbiology Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 69: Microbiology Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 70: Microbiology Culture, Republic of Korea, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 71: Microbiology Culture, Republic of Korea, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 72: Clinical Chemisty Market Pipeline Products
Table 73: Immuno Chemistry Market Pipeline Products
Table 74: Haematology Market Pipeline Products
Table 75: Infectious Immunology Market Pipeline Products
Table 76: Microbiology Culture Market Pipeline Products
Table 77: Histology And Cytology Market Pipeline Products
Table 78: Genetic Testing Market Pipeline Products
Table 79: Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company
Table 80: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
Table 81: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
Table 82: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
Table 83: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
Table 84: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
Table 85: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Table 86: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
Table 87: CML HealthCare Enters Into Agreement With MaRS Innovation
Table 88: Akrivis Technologies Enters Into Co-Development Agreement With United States Biological
Table 89: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
Table 90: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
Table 91: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
Table 92: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
Table 93: Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers
Table 94: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Table 95: Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems
Table 96: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
Table 97: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Table 98: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
Table 99: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
Table 100: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
Table 101: One Lambda Enters Into Co-Marketing Agreement With CellTrend
Table 102: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Table 103: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Table 104: Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing
Table 105: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Table 106: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Table 107: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Table 108: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
Table 109: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
Table 110: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
Table 111: LipoScience Enters Into Licensing Agreement With Cleveland Clinic
Table 112: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
Table 113: NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
Table 114: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, Republic of Korea, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics Market, Republic of Korea, Revenue Mix ($m), 2011
Figure 4: In Vitro Diagnostics Market, Republic of Korea, Category Contribution (%), 2011
Figure 5: In Vitro Diagnostics Market, Republic of Korea, Cross-Category Analysis, 2004-2018
Figure 6: In Vitro Diagnostics, Republic of Korea, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: In Vitro Diagnostics, Republic of Korea, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: In Vitro Diagnostics, Republic of Korea, Company Share (%), 2011
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, Republic of Korea, Revenue Mix ($m), 2011
Figure 11: Clinical Chemistry Market, Republic of Korea, Segment Contribution (%), 2011
Figure 12: Clinical Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: Clinical Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: Clinical Chemisty Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 15: Clinical Chemisty Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 16: Urine Analysis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 17: Urine Analysis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 18: Clinical Chemistry, Republic of Korea, Company Share (%), 2011
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, Republic of Korea, Revenue Mix ($m), 2011
Figure 21: Genetic Testing Market, Republic of Korea, Segment Contribution (%), 2011
Figure 22: Genetic Testing, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 23: Genetic Testing, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 24: Genetic Testing, Republic of Korea, Company Share (%), 2011
Figure 25: Haematology Market, Market Segmentation
Figure 26: Haematology Market, Republic of Korea, Revenue Mix ($m), 2011
Figure 27: Haematology Market, Republic of Korea, Segment Contribution (%), 2011
Figure 28: Haematology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 29: Haematology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 30: Haematology Reagents, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 31: Haematology Reagents, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 32: Immunohaematology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 33: Immunohaematology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 34: Haemostasis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 35: Haemostasis, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 36: Haematology Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 37: Haematology Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 38: Haematology Cell Counters, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 39: Haematology Cell Counters, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 40: Haematology, Republic of Korea, Company Share (%), 2011
Figure 41: Histology and Cytology Market, Market Segmentation
Figure 42: Histology And Cytology Market, Republic of Korea, Revenue Mix ($m), 2011
Figure 43: Histology And Cytology Market, Republic of Korea, Segment Contribution (%), 2011
Figure 44: Histology And Cytology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 45: Histology And Cytology, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 46: Histology And Cytology, Republic of Korea, Company Share (%), 2011
Figure 47: Immuno Chemistry Market, Republic of Korea, Revenue Mix ($m), 2011
Figure 48: Immuno Chemistry Market, Republic of Korea, Segment Contribution (%), 2011
Figure 49: Immuno Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 50: Immuno Chemistry, Republic of Korea, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 51: Disease Specific Immunochemistry, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 52: Disease Specific Immunochemistry, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 53: Drugs of Abuse / Toxicology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 54: Drugs of Abuse / Toxicology, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 55: Endocrinology Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 56: Endocrinology Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 57: Immunochemistry Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 58: Immunochemistry Rapid Tests, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 59: Therapeutic Drug Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 60: Therapeutic Drug Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 61: Immunochemistry Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 62: Immunochemistry Analyzers, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 63: Immuno Chemistry, Republic of Korea, Company Share (%), 2011
Figure 64: Infectious Immunology, Market Segmentation
Figure 65: Infectious Immunology Market, Republic of Korea, Revenue Mix ($m), 2011
Figure 66: Infectious Immunology Market, Republic of Korea, Segment Contribution (%), 2011
Figure 67: Infe
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Hematology & Oncology Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!